Skip to content LISAH Logo
  • Join
  • Login
  • News
  • Briefings
    • Search and filter
    • National access
    • International access
    • Tools and methods
    • Key topics
  • Learning
    • Access role
    • Professional associations
    • University courses
    • Webinars
    • Podcasts
    • Journals
    • Books
  • Events
    • List an event
    • Past events
    • Finding an event
  • Directory
    • List an organisation
    • Finding an organisation
  • Join
    • Free membership
    • Subscription
    • Sponsor
  • About
    • Our team
    • Frequently asked questions
    • Policies
  • Contact
  • Search
  • Join
  • Login
  1. You are here:
  2. Homepage
  3. Events
  4. Critical new HTA developments in Europe: challenges & solutions
Training CELforPharma

Critical new HTA developments in Europe: challenges & solutions

Most countries have their own Health Technology Assessment (HTA) body with specific views about which criteria to be used and how the HTA process should be conducted. On top of that, EU-level networks strive for a more efficient use of resources and increased collaboration between all stakeholders involved. In this 1-day course you will learn how companies should optimise processes and criteria in this complex environment.

18 November 2026 + Add to calendar Online

CELforPharma

Course details
Return to listing

Related events

ISPOR
25 – 26 March 2026

Primer on a 6-step approach to budget impact

Training Online
CELforPharma
21 – 22 April 2026

The pharma pricing course

Training Online
CELforPharma
22 April 2026

Market access essentials for business development and clinical strategy

Training Online
LiSAH logo reversed_edges further reduced (150 x 90 px).png

 

Life Sciences Access Hub is managed by Medica Market Access Limited, a registered company in England and Wales.

Company Registration Number 7754052
VAT Registration Number GB 120 6369 39

  • Disclaimer
  • Terms and conditions
  • Privacy policy
  • Cookie policy

© 2026 Life Sciences Access Hub | All rights reserved